We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
BD Diagnostics, a segment of BD (Becton, Dickinson), announced that it has acquired
the technology and other assets of the FFE Weber business, a privately held
company based in Munich, Germany, that specializes in the separation and fractionation
of complex proteins.
U.S.-based Aesthera announced that the FDA has cleared its photopneumatic system
for the treatment of vascular and pigmented lesions, and permanent hair reduction.
Medical devicemaker Guidant accuses the North Broward Hospital District of hiring
a consulting firm that steered a multimillion-dollar contract for pacemakers
and other cardiac devices to a company the consultant manages.
Biophan Technologies, a developer of next-generation medical technology, released
additional technical information on its research into pacemaker and implantable
defibrillator lead heating.
CTS, a provider of electronics manufacturing services, announced that the Thailand
facility of its Electronics Manufacturing Solutions (EMS) strategic business
unit has successfully achieved ISO13485:2003 certification.
Fujirebio Diagnostics (FDI), a company specializing
in oncology testing, announced that it submitted a 510(k) application to the
FDA for clearance of MESOMARK, the first blood test for mesothelioma.
CABG Medical has initiated enrollment in its clinical trial for CE Mark approval
of the Holly Graft System, a drug-eluting graft for facilitating a coronary
artery bypass procedure.
Medtronic has begun a U.S. pilot evaluation with Carematix to assess the efficacy
and convenience of remotely monitoring physiological heart data, weight and
blood pressure in the management of heart failure.